Cargando…

Anti-Kv1.4 Antibody Without Myasthenia Gravis: A Rare Cause of Autoimmune Myocarditis and Myositis

Anti-Kv1.4 antibody is often detected in thymoma-associated myasthenia gravis patients with anti-acetylcholine receptor antibody. Herein, we describe 2 patients with concurrent myocarditis and myositis. In both cases, anti-Kv1.4 antibody was positive despite the absence of thymoma and anti-acetylcho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuyama, Naoto, Takashio, Seiji, Nagakura, Takumi, Imamura, Michie, Takamatsu, Koutaro, Takae, Masafumi, Hirakawa, Kyoko, Yamanaga, Kenshi, Hanatani, Shinsuke, Yamamoto, Eiichiro, Matsushita, Kenichi, Ueda, Mitsuharu, Tsujita, Kenichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998724/ https://www.ncbi.nlm.nih.gov/pubmed/36909266 http://dx.doi.org/10.1016/j.jaccas.2023.101734

Ejemplares similares

Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis
por: Kufukihara, Kenji, et al.
Publicado: (2019)

A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
por: Nakashima, Naoya, et al.
Publicado: (2022)

Clinical characteristics and natural history of wild‐type transthyretin amyloid cardiomyopathy in Japan
por: Yamada, Toshihiro, et al.
Publicado: (2020)

HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction
por: Egashira, Koichi, et al.
Publicado: (2022)

Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild‐Type Transthyretin Amyloid Cardiomyopathy
por: Morioka, Mami, et al.
Publicado: (2022)

Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy
por: Takashio, Seiji, et al.
Publicado: (2023)

Cancer Development Associated with Cardiovascular Diseases
por: Fujisaki, Tomohiro, et al.
Publicado: (2022)

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
por: Oike, Fumi, et al.
Publicado: (2022)

Prognostic significance of liver stiffness assessed by fibrosis‐4 index in patients with heart failure
por: Takae, Masafumi, et al.
Publicado: (2021)

Prognostic value of left atrial strain in patients with wild‐type transthyretin amyloid cardiomyopathy
por: Oike, Fumi, et al.
Publicado: (2021)

A Randomized, Double-Blind Comparison Study of Royal Jelly to Augment Vascular Endothelial Function in Healthy Volunteers
por: Fujisue, Koichiro, et al.
Publicado: (2022)

Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy
por: Usuku, Hiroki, et al.
Publicado: (2023)

Effect of the ALDH2 Variant on the Prevalence of Atrial Fibrillation in Habitual Drinkers
por: Yamashita, Takayoshi, et al.
Publicado: (2022)

Clinical Features of Disaster-Related Deaths After the Kumamoto Earthquake 2016　― Comparison With the Great East Japan Earthquake 2011 ―
por: Sueta, Daisuke, et al.
Publicado: (2019)

Granulomatous Myositis Associated with Myasthenia Gravis: A Rare Case
por: Iqbal, Shumaila M, et al.
Publicado: (2019)

Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021)

Double‐chambered right ventricle complicated by hypertrophic obstructive cardiomyopathy diagnosed as Noonan syndrome
por: Yamamoto, Masahiro, et al.
Publicado: (2020)

Anti-Kv1.4 Antibody-positive Nivolumab-induced Myasthenia Gravis and Myositis Presenting with Bilateral Ptosis and Demonstrating Different Pathophysiologies
por: Kitazaki, Yuki, et al.
Publicado: (2023)

Non‐Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis
por: Hirakawa, Kyoko, et al.
Publicado: (2018)

Pembrolizumab‐induced myasthenia gravis with myositis in a patient with lung cancer
por: Hibino, Makoto, et al.
Publicado: (2018)

Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report
por: Cham, Jason, et al.
Publicado: (2021)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
por: Akasaka-Kihara, Fumie, et al.
Publicado: (2021)

Clinical, electrocardiographic, and echocardiographic parameters associated with the development of pacing and implantable cardioverter-defibrillator indication in patients with transthyretin amyloid cardiomyopathy
por: Kawahara, Yusei, et al.
Publicado: (2023)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Myositis associated to COVID-19 mimics an acute exacerbation in myasthenia gravis patient
por: De Martino, Antonio, et al.
Publicado: (2021)

Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023)

Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma
por: Virgen, Cesar A, et al.
Publicado: (2023)

Successful treatment of deep vein thrombosis caused by iliac vein compression syndrome with a single-dose direct oral anti-coagulant
por: Nakashima, Naoya, et al.
Publicado: (2017)

The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fraction
por: Komorita, Takashi, et al.
Publicado: (2020)

Multiple Giant Coronary Artery Aneurysms
por: Usuku, Hiroki, et al.
Publicado: (2017)

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia
por: Takamatsu, Koutaro, et al.
Publicado: (2018)

Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Todo, Maki, et al.
Publicado: (2019)

Camrelizumab-Related Myocarditis and Myositis With Myasthenia Gravis: A Case Report and Literature Review
por: Bai, Jing, et al.
Publicado: (2022)

Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy
por: Usuku, Hiroki, et al.
Publicado: (2022)

Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis
por: Usuku, Hiroki, et al.
Publicado: (2023)

Granulomatous Myositis Associated with Extremely Elevated Anti-striated Muscle Antibodies in the Absence of Myasthenia Gravis
por: Meegada, Sreenath, et al.
Publicado: (2020)

Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature
por: Scangarello, Frank A, et al.
Publicado: (2021)

Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report
por: Tian, Chia-Yi, et al.
Publicado: (2021)

Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report
por: Saishu, Yumi, et al.
Publicado: (2022)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1graas8sgtvsasu3qgm71mkp5i